The first-month results on semaglutide typically show 3-5 pounds of loss, with the pace accelerating as doses increase
Neither is definitively 'worse' they're different
A study published in The strongest finding in the study was that the well-established link between impulsivity and violent behavior was substantially weaker among current GLP-1 users compared to former users, Daniel Semenza, the lead author of the study, as well as the director of research at the New Jersey Gun Violence Research Center at the Rutgers School of Public Health, and an associate professor with the Rutgers School of Public Health, said in a press release
DSIP and Semax are different research neuropeptides
extracted coniferyl ferulate from the roots of Angelica sinensis and demonstrated that the isolated compound is a robust inhibitor of the isozymes of glutathione S-transferase, which, in addition to their other vital functions, contribute to chemoresistance as well as enhance chemosensitivity [205]